glp-1 receptor agonist medicines Agonists: An Alternative for Rapid-Acting Insulin? Benefits and Risks of GLP-1
Description
Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and isoglycemic intravenous glucose
Stimulation of -cell proliferation secondary to stimulating GLP-1R is usually only observed in young animals (during periods characterized by preserved proliferative capacity), and not in older rodents [548]
In a 2019 research summary, the agency noted: More than 2 million people now use exenatide worldwide. Part V: The Evolution of an Idea Byetta was a proof of concept, but it had limitations
Patients should be advised of these adverse effects prior to prescription
